| Zacks Company Profile for IGC Pharma, Inc. (IGC : AMEX) |
|
|
| |
| • Company Description |
| IGC Pharma Inc. develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. IGC Pharma Inc., formerly known as India Globalization Capital Inc., is based in POTOMAC, Md.
Number of Employees: 70 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.41 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 6,380,949 shares |
| Shares Outstanding: 79.68 (millions) |
| Market Capitalization: $33.07 (millions) |
| Beta: 1.45 |
| 52 Week High: $0.50 |
| 52 Week Low: $0.25 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
33.87% |
28.86% |
| 12 Week |
46.28% |
23.04% |
| Year To Date |
23.51% |
15.67% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
10224 FALLS ROAD
-
POTOMAC,MD 20854
USA |
ph: 301-983-0998
fax: 240-465-0273 |
info@igcinc.us |
https://igcpharma.com |
|
|
| |
| • General Corporate Information |
Officers
Ram Mukunda - Chief Executive Officer; President and Director
Richard Prins - Chairman of the Board of Directors
Claudia Grimaldi - Vice President; Principal Financial Officer; Chief
Rohit Goel - Principal Accounting Officer
James Moran - Director
|
|
Peer Information
IGC Pharma, Inc. (GSAC)
IGC Pharma, Inc. (CASI)
IGC Pharma, Inc. (ALCD.)
IGC Pharma, Inc. (OMNN)
IGC Pharma, Inc. (CGPI.)
IGC Pharma, Inc. (CATX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 45408X308
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
|
|
Share - Related Items
Shares Outstanding: 79.68
Most Recent Split Date: 4.00 (0.10:1)
Beta: 1.45
Market Capitalization: $33.07 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $-0.03 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $-0.11 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/14/25 |
|
|
|
| |
